| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |